ZY Stock Down 74%, Zymergen Expects No Product Revenue in 2021-2022
Zymergen announced that CEO Josh Hoffman has stepped down and will be replaced by Jay Flatley as the acting Chief ...
Read moreDetailsZymergen announced that CEO Josh Hoffman has stepped down and will be replaced by Jay Flatley as the acting Chief ...
Read moreDetailsZymergen announced that CEO Josh Hoffman has stepped down and will be replaced by Jay Flatley as the acting Chief...
© 2018 JNews by Jegtheme.